Ultragenyx Pharmaceutical Inc
LSE:0LIF
Ultragenyx Pharmaceutical Inc
LSE:0LIF
Price:
23.02
USD
1.54%
Market Closed
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ultragenyx Pharmaceutical Inc
LSE:0LIF
|
US |
|
Grifols SA
F:OZTA
|
ES |
|
G
|
Globe Life Inc
DUS:TMJ
|
US |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
C
|
Compass Inc
NYSE:COMP
|
US |
|
Industrivarden AB
F:IDV1
|
SE |
|
A
|
ADT Inc
F:541
|
US |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
PDF Solutions Inc
NASDAQ:PDFS
|
US |
|
W
|
Warner Bros Discovery Inc
DUS:J5A
|
US |
|
Northam Platinum Holdings Ltd
OTC:NPTLF
|
ZA |
|
K
|
KKR & Co Inc
F:KR51
|
US |
|
J
|
Jiangsu Expressway Co Ltd
F:JE2
|
CN |
|
P
|
Precigen Inc
F:I5X
|
US |
|
F
|
Five Below Inc
F:6F1
|
US |
|
Wilmar International Ltd
SGX:F34
|
SG |
|
S
|
Swatch Group AG
XMUN:UHRN
|
CH |
|
J
|
Jasmine International PCL
SET:JAS
|
TH |
|
ON Semiconductor Corp
NASDAQ:ON
|
US |
|
Robinhood Markets Inc
BMV:HOOD
|
US |
|
A
|
Annaly Capital Management Inc
F:AAY
|
US |
|
R
|
Riley Exploration Permian Inc
F:T7U
|
US |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
I
|
Inter Pharma PCL
SET:IP
|
TH |
Wall St Price Targets
0LIF Price Targets Summary
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc
Wall Street analysts forecast 0LIF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0LIF is 52.58 USD with a low forecast of 25.18 USD and a high forecast of 87.97 USD.
Lowest Forecast
Price Target
25.18
USD
9% Upside
Average Forecast
Price Target
52.58
USD
128% Upside
Highest Forecast
Price Target
87.97
USD
282% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0LIF's stock price target?
Price Target
52.58
USD
52.58
USD
According to Wall Street analysts, the average 1-year price target for 0LIF is 52.58 USD with a low forecast of 25.18 USD and a high forecast of 87.97 USD.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
